Micronutrient deficiencies and altered mineral metabolism associated with wasting malnutrition are potential risk factors for death among African patients referred for anti-retroviral therapy (ART). NUSTART is a randomized controlled phase III trial of a lipid-based nutrient supplement (LNS) without or with vitamins and bulk minerals during the first weeks after referral for ART. Participant involvement is complete; data and frozen serum samples are available for analysis, if approved by the NUSTART study team.
| Douglas Heimburger [Email] Vanderbilt Institute for Global Health |
|
| Location |
Mwanza, Tanzania; Lusaka, Zambia |
| Contacts |
Other faculty: John R. Koethe [Email] |
| Program Type |
Research |
| Funding Type |
N/A |
| Region |
Africa |
| Global Health Topics |
HIV/AIDS, Infectious Diseases, Nutrition, Public Health |
| Eligibility |
Graduate students (non-clinical); Medical students (MD); Post-doctoral students, residents, or trainees; Faculty members |
| Program Length |
1 to 3 months, 3 to 6 months, 6 to 12 months, 1 year or more |
| VU Affiliation |
The program is affiliated with Vanderbilt. |
| Language(s) |
The program does not have a language requirement. |